Company Overview

Iterum Therapeutics plc is an Ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. These products are aimed at combating the global crisis of multi-drug resistant (MDR) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. Iterum’s first product is a novel anti-infective compound that has demonstrated potent in-vitro activity vs. a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics.

Sign up here to receive notices about press releases and SEC filings.

Stock Information

Upcoming Events

American Society for Microbiology (ASM) Microbe 2024

June 16, 2024 • 10:00am - 4:00am EDT

View All Events

Investor Contact Information

Investor Relations